GlassScriptPhysician profile
William Michael Roberts
NPI 1336138650
$3,238.67
in general payments reported to CMS, 2019-2025
35 companies · $737 in 2025
The $737 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $219 · 2021: $320 · 2022: $504 · 2023: $454 · 2024: $547 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,042.74 | 2021-2025 | Botox, Ubrelvy |
| Medtronic, INC. | $342.70 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Allergan, INC. | $261.05 | 2021-2022 | |
| Si-Bone, INC. | $158.43 | 2019-2025 | |
| Nevro Corp. | $157.31 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.45 | 2019-2023 | Relistor |
| Radius Health, INC. | $151.91 | 2022-2023 | Tymlos |
| Amgen INC. | $107.63 | 2019-2021 | |
| Horizon Therapeutics Plc | $105.11 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $70.85 | 2025 | |
| Abbott Laboratories | $63.18 | 2019-2025 | Eterna |
| Avanos Medical | $52.17 | 2025 | Standard Rf Disposables, Generator |
| Lilly USA, LLC | $46.02 | 2019-2021 | |
| Averitas Pharma INC. | $40.31 | 2024 | Qutenza |
| Kyowa Kirin, INC. | $40.03 | 2024-2025 | Crysvita |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $37.74 | 2024-2025 | Sprint Pns System |
| Pfizer INC. | $36.40 | 2019 | |
| Almatica Pharma LLC | $32.09 | 2025 | Loreev Xr |
| Sanofi-Aventis U.S. LLC | $30.83 | 2019-2020 | |
| Stryker Corporation | $28.86 | 2024 | Mild Device Kit |
| Biodelivery Sciences International, INC. | $25.63 | 2020 | |
| Tersera Therapeutics LLC | $25.06 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.23 | 2019-2020 | |
| Medtronic USA, INC. | $23.74 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $22.78 | 2024 | Strensiq |
| Novartis Pharmaceuticals Corporation | $21.03 | 2019 | |
| Daiichi Sankyo INC. | $18.89 | 2019 | |
| Bausch & Lomb Americas INC. | $18.28 | 2025 | Envista Envy Iol |
| Saol Therapeutics INC. | $17.91 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.22 | 2020 | |
| Boston Scientific Corporation | $15.75 | 2025 | Intracept |
| Shionogi INC | $15.11 | 2019 | |
| Avanir Pharmaceuticals, INC. | $12.74 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $11.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.